Tender For E-Tender For Procurement Of Drug Items Under Table-A, For Two Years From The Date Of Aoc
Tender Overview
Project Description
Tender for E-Tender For Procurement Of Drug Items Under Table-A, For Two Years From The Date Of Aoc , Aciclovir Syrup / Oral Suspension, 200Mg/5Ml , Adenosine Inj. U.S.P. 3 Mg / Ml In 2 Ml. , Amikacin Inj. I.P. 500Mg / 2Ml.Vial , Amoxicillin 200Mg With Clavulanic Acid 28.5Mg / 5Ml Syrup I.P , Amoxicillin 250Mg With Clavulanic Acid 125 Mg Tab. , Amoxicillin 500Mg + Clavulanic Acid 125Mg Tab , Amoxicillin Cap I.P 500 Mg , Aprepitant Tab/Cap 125/80/80 Combiblister Pack , Bevacizumab 100Mg Inj. , Bevacizumab Inj. 400Mg/Vial , Calcium Carbonate Equivalent To Elemental Calcium 200 Mg And Vit D3 200 Iu/5Ml Syrup , Calcium Phosphate Equivalent To Elemental Calcium 82 Mg And Vit D3 200 Iu/5Ml Syrup , Cefotaxime Sodium Powder For Inj. I.P. 250Mg / Vial , Ceftriaxone Inj. B.P. 250Mg Vial. , Cefuroxime Axetil Syrup 125Mg/5 Ml , Chlorpromazine Hcl Tab Ip 25Mg , Ciprofloxacin Inj. I.P. 2Mg/Ml , Clindamycin Ointment 1% , Clomipramine Tab. 25 Mg , Dextrose Inj.I.P. 25% In 100 Ml Bot. , Dextrose Solution Inj. I.P. 5% (Flow, Fill & Seal Process) , Diethylcarbamazin 50 Mg Tab. , Drotavarine Syrup.I.P. 10 Mg/5Ml , Ergometrine Maleate Inj.B.P. 0.2Mg/Ml. In 1 Ml Ampoule , Erlotinib Tab 100 Mg , Ethionamide 125 Mg Tab. , Glimipride 4 Mg Tab , Luliconazole Cream 1% W/W , Mephentermine Inj. I.P. 15 Mg/ 1 Ml. annual periodical maintenance , Meropenam Inj. 125Mg./Vial. , Metronidazole Infusion I.P. 5 Mg / Ml.- Bot. Of 100Ml , Mifepristone 200 Mg Tab. , Permithrin 5% Lotion , Phenobarbitone 60 Mg Tab. , Phenobarbitone Sodium I.P. 30 Mg Tab. , Phenobarbitone Sodium Inj. I.P.200 Mg In 1Ml Amp. , Phenytoin Oral Suspention B.P. 25 Mg /Ml , Sodium Chloride & Dextrose Injection I.P. (Form, Fill & Seal Process) , Sodium Chloride Inj. Ip 0.9% W/V 100 Ml Ffs , Vit. - K Inj. 10Mg/Ml (Phytomenadione / Menadione) , Important Note: 1. All Prospective Bidders Are Requested To Quote The Rate In Boq As Per Accounting Unit & Item Specification As Mentioned In The Table-A. Wrong Quoting Of The Rate In Boq Will Be Dealt With As Per Penal Provisions Of The T&C Of The Tender. 2. Tendered Quantity Is Just A Tentative Quantity And Should Not Be Treated As Final. It May Increase Or Decrease, As Per Need Of The State. Keeping This In Mind, The Supplier Is Not Allowed To Seek Termination Of The Rate Contract After Finishing Supply Of Tendered Quantity. 3. Quality Of The Product Supplied, May Be Ascertained By Testing / Physical Examination By The Experts At Any Stage Of The Tender Period. 4. The Prospective Bidders Of The Said Tender Are Requested To Make A Declaration In Affidavit Under Annexure Vi(B) In Case Of Sole Manufacturer/Importer (I.E. Proprietary In Nature). 5. If The Item(S) Under Sole Manufacturer / Importer Is (Are) Proprietary In Nature, Quarterly Intimation Is Solicited From The Approved Bidders Positively Regarding The Status Of Their Item(S) Proprietary In Nature, Otherwise Their Item(S) Will Be Blocked In The Smis. 6. In Case Of Tie Bid, Decision Will Be Taken By The Tia As Per G.O. No. 2320-F(Y), Dated 07.06.2022 Issued From Finance Department Audit Branch (Group T).
Corrigendum
| Sr No | Corrigendum Date | Corrigendum | Type | New Submission Date |
|---|---|---|---|---|
| 1 | 20-Jul-2026 | Revised Technical Data Sheet | Other | 06-Aug-2026 |
| 2 | 20-Jul-2026 | Corrigendum_1 | BOQ | 06-Aug-2026 |
BOQ
| Sl. No. | Item Description |
| 1 | Aciclovir Syrup / Oral Suspension, 200mg/5ml |
| 2 | Adenosine Inj. U.S.P. 3 mg / ml in 2 ml. |
| 3 | Amikacin Inj. I.P. 500mg / 2ml.Vial |
| 4 | Amoxicillin 200mg with Clavulanic Acid 28.5mg / 5ml Syrup I.P |
| 5 | Amoxicillin 250mg with Clavulanic Acid 125 mg Tab. |
| 6 | Amoxicillin 500mg + Clavulanic Acid 125mg Tab |
| 7 | Amoxicillin Cap I.P 500 mg |
| 8 | Aprepitant tab/Cap 125/80/80 Combiblister pack |
| 9 | Bevacizumab 100mg Inj. |
| 10 | Bevacizumab Inj. 400mg/Vial |
| 11 | Calcium Carbonate Equivalent to elemental Calcium 200 mg and Vit D3 200 IU/5ml Syrup |
| 12 | Calcium Phosphate Equivalent to elemental Calcium 82 mg and Vit D3 200 IU/5ml Syrup |
| 13 | Cefotaxime Sodium Powder for Inj. I.P. 250mg / Vial |
| 14 | Ceftriaxone inj. B.P. 250mg vial. |
| 15 | Cefuroxime Axetil Syrup 125mg/5 ml |
| 16 | Chlorpromazine HCl Tab IP 25mg |
| 17 | Ciprofloxacin Inj. I.P. 2mg/ml |
| 18 | Clindamycin Ointment 1% |
| 19 | Clomipramine Tab. 25 mg |
| 20 | Dextrose Inj.I.P. 25% in 100 ml bot. |
| 21 | Dextrose Solution Inj. I.P. 5% (Flow, Fill & seal Process) |
| 22 | Diethylcarbamazin 50 mg Tab. |
| 23 | Drotavarine Syrup.I.P. 10 mg/5ml |
| 24 | Ergometrine Maleate Inj.B.P. 0.2mg/ml. in 1 ml Ampoule |
| 25 | Erlotinib Tab 100 mg |
| 26 | Ethionamide 125 mg Tab. |
| 27 | Glimipride 4 mg Tab |
| 28 | Luliconazole cream 1% w/w |
| 29 | Mephentermine Inj. I.P. 15 mg/ 1 ml. Amp |
| 30 | Meropenam Inj. 125mg./Vial. |
| 31 | Metronidazole Infusion I.P. 5 mg / ml.- Bot. of 100ml |
| 32 | Mifepristone 200 mg Tab. |
| 33 | Permithrin 5% lotion |
| 34 | Phenobarbitone 60 mg Tab. |
| 35 | Phenobarbitone Sodium I.P. 30 mg Tab. |
| 36 | Phenobarbitone Sodium Inj. I.P.200 mg in 1ml Amp. |
| 37 | Phenytoin Oral Suspention B.P. 25 mg /ml |
| 38 | Sodium Chloride & Dextrose Injection I.P. (Form, Fill & Seal Process) |
| 39 | Sodium Chloride Inj. IP 0.9% w/v 100 ML FFS |
| 40 | Vit. - K Inj. 10mg/ml (Phytomenadione / Menadione) |
| 41 | Important Note: 1. All prospective bidders are requested to quote the rate in BOQ as per Accounting Unit & item specification as mentioned in the Table-A. Wrong Quoting of the rate in BOQ will be dealt with as per penal provisions of the T&C of the Tender.2. Tendered quantity is just a tentative quantity and should not be treated as final. It may increase or decrease, as per need of the state. Keeping this in mind, the supplier is not allowed to seek termination of the Rate Contract after finishing supply of tendered quantity.3. Quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period.4. The prospective Bidders of the said Tender are requested to make a declaration in Affidavit under Annexure VI(b) in case of sole manufacturer/importer (i.e. proprietary in nature).5. If the Item(s) under sole manufacturer / importer is (are) Proprietary in nature, quarterly intimation is solicited from the approved Bidders positively regarding the status of their Item(s) Proprietary in nature, otherwise their Item(s) will be blocked in the SMIS.6. In case of Tie Bid, decision will be taken by the TIA as per G.O. No. 2320-F(Y), dated 07.06.2022 issued from Finance Department Audit Branch (Group T). Please Enable Macros to View BoQ information |
AI Tender Summary
Tender Timeline
Tender Published
Tender notice published.
CompletedCorrigendum-1 Issued
Clarifications on tender conditions and amendments issued.
Upcoming · 16 daysCorrigendum-2 Issued
Clarifications on tender conditions and amendments issued.
Upcoming · 16 daysBid Submission Deadline
Online submission via eProcurement portal.
Upcoming · 16 daysTender Documents
Download All (ZIP) ↓We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender